149 related articles for article (PubMed ID: 35624327)
1. CGB5, INHBA and TRAJ19 Hold Prognostic Potential as Immune Genes for Patients with Gastric Cancer.
Ji B; Qiao L; Zhai W
Dig Dis Sci; 2023 Mar; 68(3):791-802. PubMed ID: 35624327
[TBL] [Abstract][Full Text] [Related]
2. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
[TBL] [Abstract][Full Text] [Related]
3. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
5. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
[TBL] [Abstract][Full Text] [Related]
6. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
[TBL] [Abstract][Full Text] [Related]
7. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
8. Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysis.
Liu F; Liu J; Shi X; Hu X; Wei L; Huo B; Chang L; Han Y; Liu G; Yang L
Sci Rep; 2023 Aug; 13(1):12494. PubMed ID: 37528145
[TBL] [Abstract][Full Text] [Related]
9. CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer.
Yang Y; Shi Y; Hou Y; Lu Y; Yang J
Cancer Med; 2018 Mar; 7(3):716-725. PubMed ID: 29473345
[TBL] [Abstract][Full Text] [Related]
10. LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics.
Xu W; Chen S; Jiang Q; He J; Zhang F; Wang Z; Ruan C; Shi B
BMC Gastroenterol; 2023 Dec; 23(1):455. PubMed ID: 38129820
[TBL] [Abstract][Full Text] [Related]
11. Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
Zeng L; Sun X
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984496
[No Abstract] [Full Text] [Related]
12. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
13. Identification of hub genes and construction of an mRNA-miRNA-lncRNA network of gastric carcinoma using integrated bioinformatics analysis.
Wei G; Dong Y; He Z; Qiu H; Wu Y; Chen Y
PLoS One; 2021; 16(12):e0261728. PubMed ID: 34968391
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
15. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
16. Identification of Immune-Related Prognostic Markers in Gastric Cancer.
He Y; Song H; Jiang Y; Ren W
J Healthc Eng; 2022; 2022():7897274. PubMed ID: 35299682
[TBL] [Abstract][Full Text] [Related]
17. M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer.
Liang ZW; Yu J; Gu DM; Liu XM; Liu J; Wu MY; Xu MD; Shen M; Duan W; Li W
J Cell Mol Med; 2022 Mar; 26(5):1540-1555. PubMed ID: 35150061
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
[TBL] [Abstract][Full Text] [Related]
19. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Dai DQ
Pathol Res Pract; 2019 May; 215(5):893-899. PubMed ID: 30718100
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
Ito S; Masuda T; Noda M; Hu Q; Shimizu D; Kuroda Y; Eguchi H; Tobo T; Utsunomiya T; Mimori K
Oncology; 2020; 98(7):501-511. PubMed ID: 32380498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
